Jingli Zhang

3.4k citations
80 papers · 2.4k indexed · h-index 27
Topics
Occupational and environmental lung diseases (23 papers)Pleural and Pulmonary Diseases (8 papers)Cancer Research and Treatments (6 papers)

In The Last Decade

Jingli Zhang

74 papers receiving 2.4k citations

Peers

Jingli Zhang
Comparison fields: 5 of 132
  • Pulmonary and Respiratory Medicine 770
  • Molecular Biology 744
  • Oncology 571
  • Immunology 507
  • Biotechnology 361
Replace Yili Wang with:
Yili Wang China
Akinobu Gotoh Japan
Xiuwen Wang China
Antonino Bruno Italy
Subhankar Chakraborty United States
Ying Liang China
Min Huang China
Yoshinori Inagaki Japan
Jingli Zhang relative to Yili Wang China Yili Wang's profile →
Citations per field
00.5×3.8×
Yili Wang · 1×
Citations per year

Countries citing papers authored by Jingli Zhang

Since Specialization
Citations

This map shows the geographic impact of Jingli Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingli Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingli Zhang more than expected).

Fields of papers citing papers by Jingli Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingli Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingli Zhang. The network helps show where Jingli Zhang may publish in the future.

Co-authorship network of co-authors of Jingli Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingli Zhang. A scholar is included among the top collaborators of Jingli Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingli Zhang. Jingli Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 1
4 9
5 31
6 35
7 43
8 12
9 30
10 19
11 33
12 16
13 153
14 77
15 45
16 39
17 50
18
Comparison between expression of Ki-67 and PCNA in breast carcinoma
0
19 9
20 75

About Jingli Zhang

Jingli Zhang is a scholar working on Biotechnology, Pulmonary and Respiratory Medicine and Oncology, having authored 80 papers that have together received 2.4k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (23 papers), Pleural and Pulmonary Diseases (8 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Biotechnology (361 citations), Immunology (507 citations) and Pulmonary and Respiratory Medicine (770 citations). Jingli Zhang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Raffit Hassan, Ira Pastan, Masanori Onda, Mitchell Ho, Anish Thomas, Seth M. Steinberg, Dipak Ghosh, Husam M. Abu‐Soud, Markku Miettinen and Maureen Sampson. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026